The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Infection

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JINF.2005.08.022PMID 16427702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The invasive and saprophytic syndromes due to Aspergillus spp.

  2005cited by this paper
• Voriconazole: therapeutic review of a new azole antifungal

  2004influential reference
• Validation of an Assay for Voriconazole in Serum Samples Using Liquid Chromatography-Tandem Mass Spectrometry

  2004influential reference
• Clinical Manifestations and Treatment Outcomes of Pulmonary Aspergilloma

  2004cited by this paper
• In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp

  2003cited by this paper
• Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review.

  2003cited by this paper
• Chronic pulmonary aspergillosis: current classification and therapy.

  2003cited by this paper
• Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.

  2002cited by this paper
• Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

  2002cited by this paper
• Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis.

  2001cited by this paper
• Chronic forms of pulmonary aspergillosis.

  2001influential reference
• Chronic necrotizing pulmonary aspergillosis: approach to management.

  1997influential reference
• [Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Pulmonary Aspergilloma Study Group].

  1997cited by this paper
• Indications and outcome of surgery for pulmonary aspergilloma.

  1997cited by this paper
• Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy.

  1996cited by this paper
• Treatment of pulmonary aspergilloma with itraconazole.

  1991cited by this paper
• Adverse events associated with itraconazole in 189 patients on chronic therapy.

  1990cited by this paper
• Chronic Necrotizing Pulmonary Aspergillosis: A Discrete Clinical Entity

  1982cited by this paper
• "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung.

  1981cited by this paper

• Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial.

  2025cites this paper
• Aspergilloma mimicking postoperative recurrence of squamous cell lung cancer: A case report

  2025cites this paper
• Clinical and Radiological Response to Antifungal Treatment in Aspergilloma

  2025cites this paper
• Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges

  2024cites this paper
• Clinical Features, Treatment Outcome and Potential risk Factors for Recurrence Among Patients with Chronic Pulmonary Aspergillosis in a Resource–limited Setting: A Retrospective Observational Study

  2024cites this paper
• Long term management of people with post-tuberculosis lung disease

  2024cites this paper
• Endobronchial amphotericin B to treat hemoptysis in an inoperable patient with aspergillosis

  2024cites this paper
• Systemic Antifungal Therapy for Invasive Pulmonary Infections

  2023cites this paper
• Role of C-Reactive Protein and Erythrocyte Sedimentation Rate in the Diagnosis and Monitoring of Treatment Response in Treatment Naïve Subjects with Chronic Pulmonary Aspergillosis

  2023cites this paper
• Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review.

  2023cites this paper
• Pathogenicity and virulence of Aspergillus fumigatus

  2023cites this paper
• Pulmonary aspergillosis: diagnosis and treatment

  2022cites this paper
• Chronic Pulmonary Aspergillosis: A Brief Review

  2021cites this paper
• Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan

  2021cites this paper
• Utility of St. George’s respiratory questionnaire in predicting clinical recurrence in chronic pulmonary aspergillosis

  2021cites this paper
• Pulmonary oxalosis in pulmonary aspergillosis syndrome.

  2020cites this paper
• Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis

  2020influential citation
• Surgical Outcome of Chronic Pulmonary Aspergilloma: An Experience from Two Tertiary Referral Hospitals in Addis Ababa, Ethiopia

  2020influential citation
• An overview of the available treatments for chronic cavitary pulmonary aspergillosis

  2020cites this paper
• Risk factors for relapse of chronic pulmonary aspergillosis after discontinuation of antifungal therapy

  2020cites this paper
• DEVELOPMENT OF A LIQUID ORAL IN-SITU GEL OF VORICONAZOLE FOR SUSTAINED RELEASE AND ENHANCED BIOAVAILABILITY: EQUIVALENCE TESTING USING EARTH MOVER'S DISTANCE

  2020cites this paper
• Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist

  2020cites this paper
• A Collaborative Tale of Diagnosing and Treating Chronic Pulmonary Aspergillosis, from the Perspectives of Clinical Microbiologists, Surgical Pathologists, and Infectious Disease Clinicians

  2020cites this paper
• Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis.

  2019cites this paper
• Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers.

  2019cites this paper
• Evaluation of LDBio Aspergillus ICT Lateral Flow Assay for IgG and IgM Antibody Detection in Chronic Pulmonary Aspergillosis

  2019cites this paper
• Clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI

  2019cites this paper
• Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis

  2018cites this paper
• A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention

  2018cites this paper
• Current Opinion in Infectious Diseases Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences

  2018cites this paper
• The spectrum of pulmonary aspergillosis.

  2018cites this paper
• Title Intravenous micafungin versus voriconazole for chronic pulmonaryaspergillosis : A multicenter trial in Japan .

  2017cites this paper
• The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach

  2017cites this paper
• Pulmonary solid tumor with coexisting pulmonary aspergillosis: case reports and literature review

  2017cites this paper
• Recent advances in chronic pulmonary aspergillosis.

  2016cites this paper
• Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?

  2016cites this paper
• CT Imaging Assessment of Response to Treatment in Chronic Pulmonary Aspergillosis.

  2016cites this paper
• Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

  2016cites this paper
• Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry

  2015cites this paper
• Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran

  2015cites this paper
• Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

  2015cites this paper
• Antibody testing in aspergillosis--quo vadis?

  2015cites this paper
• [Pathogenesis of chronic necrotizing pulmonary aspergillosis].

  2015cites this paper
• [Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].

  2014cites this paper
• Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma

  2014cites this paper
• Chronic pulmonary aspergillosis

  2014cites this paper
• Chronic Pulmonary Aspergillosis: An Update on Diagnosis and Treatment

  2014cites this paper
• Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis.

  2013cites this paper
• The pharmacodynamics of antifungal agents against Aspergillus

  2013cites this paper
• Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature

  2013cites this paper
• Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis

  2013cites this paper
• Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature.

  2012cites this paper
• Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial

  2012cites this paper
• Aspergillus bronchitis without significant immunocompromise

  2012cites this paper
• Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan

  2012cites this paper
• Management of chronic pulmonary aspergillosis

  2012cites this paper
• Global burden of chronic pulmonary aspergillosis complicating sarcoidosis

  2012cites this paper
• Multifocal pulmonary aspergillomas: case series and review

  2012cites this paper
• Successful Treatment of Liver Aspergilloma by Caspofungin Acetate First-Line Therapy in a Non-Immunocompromised Patient

  2012cites this paper
• Antifungal activity of amphotericin B conjugated to carbon nanotubes.

  2011cites this paper
• Allergic Bronchopulmonary Aspergillosis and Related Allergic Syndromes

  2011cites this paper
• Triazole Antifungal Agents in Invasive Fungal Infections

  2011cites this paper
• A case of pulmonary aspergilloma and actinomycosis.

  2011cites this paper
• Antifungal Activity of Antifungal Drugs, as Well as Drug Combinations Against Exophiala dermatitidis

  2011cites this paper
• Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.

  2011cites this paper
• Infectiologie respiratoire et poumon de l’allogreffé de moelle

  2011cites this paper
• Endogenous aspergillus endophthalmitis after kidney transplantation.

  2011cites this paper
• Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance

  2010cites this paper
• [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].

  2010cites this paper
• Therapy for fungal diseases: opportunities and priorities.

  2010cites this paper
• Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases.

  2010cites this paper
• Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.

  2010cites this paper
• Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.

  2010cites this paper
• Neuropathie périphérique sous voriconazole au cours d’une aspergillose pulmonaire cavitaire chronique

  2010cites this paper
• Chronic Cavitary Pulmonary Aspergillosis and Fungal Balls

  2009cites this paper
• Noninvasive pulmonary Aspergillus infections.

  2009cites this paper
• Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections

  2009cites this paper
• Comparison of Aspergillus galactomannan antigen testing with a new cut‐off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis

  2009cites this paper
• Recomendaciones del tratamiento antifúngico en pacientes con bajo grado de inmunosupresión

  2008cites this paper
• [Recommendations of antifungal treatment in patients with low grade immunosuppression].

  2008cites this paper
• Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

  2008influential citation
• Therapeutic drug monitoring for triazoles

  2008cites this paper
• Tratamiento de la Aspergilosis: Guías para la práctica clínica de la Sociedad de Enfermedades Infecciosas de los Estados Unidos de América (IDSA)

  2008cites this paper
• Pharmacokinetics of voriconazole in horses and alpacas

  2008cites this paper
• Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients.

  2007cites this paper
• Infections aspergillaires broncho-pulmonaires du sujet non immunodéprimé

  2007cites this paper
• [Bronchopulmonary aspergillosis infections in the non-immunocompromised patient].

  2007cites this paper
• Aspergillosis: spectrum of disease, diagnosis, and treatment.

  2006cites this paper
• Aspergillus bronchitis without significant immunocompromise

  year unknowncites this paper
• Endogenous endophthalmitis after kidney transplantation

  year unknowncites this paper